Measurement of DNA adducts in cells exposed to cisplatin

Analytical Biochemistry

Volumn 333, Issue 1, 2004, Pages 65-71

  Iijima, Herbert ^a   Patrzyc, Helen B ^a   Dawidzik, Jean B ^a   Budzinski, Edwin E ^a   Cheng, Han Chun ^a   Freund, Harold G ^a   Box, Harold C ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CELL CULTURE; CELLS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEGATIVE IONS;

BI-FUNCTIONAL; ION CURRENTS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); MONOPHOSPHATES; MOUSE-FIBROBLASTS; MULTIPLE REACTION MONITORING; PHOSPHODIESTER BONDS; PURINE BASIS;

DNA;

ADENINE NUCLEOTIDE; AMMONIA; CISPLATIN; DINUCLEOSIDE PHOSPHATE; DNA; ESTER DERIVATIVE; GUANOSINE; ION; ISOTOPE; PHOSPHODIESTER; PURINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL; CHEMICAL BOND; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA EXTRACTION; DNA ISOLATION; DRUG EXPOSURE; ELUTION; FEASIBILITY STUDY; FIBROBLAST; ION CURRENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; TANDEM MASS SPECTROMETRY; TIME;

EID: 4444261789     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.06.001     Document Type: Article

References (29)

1. P. Jordan, and M. Carmo-Fonseca Molecular mechanisms involved in cisplatin cytotoxicity Cell Mol. Life Sci. 57 2000 1229 1235
2. J.T. Drummond, A. Anthoney, R. Brown, and P. Karren Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumour cell line J. Biol. Chem. 271 1997 19645 19648
3. S. Aebi, B. Kurdi-Haidar, R. Gordon, B. Cenni, H. Zheng, D. Fink, R.D. Christen, C.R. Boland, M. Koi, R. Fishel, and S.B. Howell Loss of DNA mismatch repair in acquired resistance to cisplatin Cancer Res. 56 1996 3087 3090
4. A. Vaisman, M. Varchenko, A. Umar, T.A. Kunkel, J.I. Risinger, and J.C. Barrett The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts Cancer Res. 58 1998 3579 3585
5. D. Fink, S. Nebel, P.S. Norris, R.N. Baergen, S.P. Wilcynski, M.J. Costa, S.A. Cannistra, and S.B. Howell Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin Int. J. Cancer 77 1998 741 746
6. B. Koberle, K.A. Grimaldi, A. Sunters, J.A. Hartley, L.R. Kelland, and J.R.W. Masters DNA repair capacity and cisplatin sensitivity of human testis tumour cells Int. J. Cancer 70 1997 551 555
7. B. Koberle, J.R.W. Masters, J.A. Hartley, and R.D. Wood Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours Curr. Biol. 9 1999 273 276
8. T.R. Durnkern, G. Fritz, and B. Kaina Cisplatin-induced apoptosis in 43-3B and 27-1 cells defective in nucleotide excision repair Mutat. Res. 486 2001 249 258
9. S. Hector, W. Bolanowska-Higdon, J. Zdanowicz, S. Hitt, and L. Pendyala In vitro studies on the mechanisms of oxaliplatin resistance Cancer Chemother. Pharmacol. 48 2001 398 406
10. A. Eastman, and N. Schulte Enhanced DNA repair as mechanism of resistance to cis diamminedichloroplatinum (II) Biochemistry 27 1988 4730 4734
11. A. Eastman Activation of programmed cell death by anticancer agents: cisplatin as a model system Cancer Cells 2 1990 275 280
12. J. Gong, A. Costanzo, H.-Q. Yang, G. Melino, W.G. Kaelin, M. Levrero, and J.Y.J. Wang The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage Nature 399 1999 806 809
13. K.V. Ferry, D. Fink, S.W. Johnson, S. Nebel, T.C. Hamilton, and S.B. Howell Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells Biochem. Pharmacol. 57 1999 861 867
14. D. Fink, H. Zheng, P.S. Nebel, S. Aebi, T.-P. Lin, H. Nehme, R.D. Christen, M. Haas, C.L. MacLeod, and S.B. Howell In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair Cancer Res. 57 1997 1841 1845
15. S. Aebi, D. Fink, R. Gordon, H.K. Kim, H. Zheng, J.L. Fink, and S.B. Howell Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells Clin. Cancer Res. 3 1997 1763 1767
16. A.M.J. Fichtinger-Schepman, J.L. van der Veer, J.H.J. den Haarogog, P.H.M. Lohman, and J. Reedijk Adducts of the antitumor drug cis- diamminedichloroplatinum (II) with DNA: formation, identification, and quantitation Biochemistry 24 1985 707 713
17. A. Eastman Reevaluation of interaction of cis-dichloro(ethylenediamine) platinum (II) with DNA Biochemistry 25 1986 3912 3915
18. R. Da Col, L. Silvestro, C. Baiocchi, D. Giacosa, and I. Viano High-performance liquid chromatographic-mass spectrometric analysis of cis-dichlorodiamineplatiumâ€"DNA complexes using an ionspray interface J. Chromatogr. 633 1993 119 128
19. U. Warnke, J. Gysler, B. Hofte, U.R. Tjaden, J. van der Greef, C. Kloft, W. Schunack, and U. Jaehde Novel platinum compounds in glioma cells: genomics and proteomics Electrophoresis 22 2001 97 103
20. T. Hagemeister, and M. Linscheld Mass spectrometry of cis-dinucleosidemonophosphates d(ApG, d(GpG) and d(TpC) in an ion trap J. Mass Spectrom. 37 2002 731 747
21. J.B. Dawidzik, H.B. Patrzyc, H. Iijima, E.E. Budzinski, A.J. Higbee, H.-C. Cheng, and H.C. Box DNA damage measured by liquid chromatography-mass spectrometry in mouse fibroblast cells exposed to oxidative stress Biochim. Biophys. Acta 1621 2003 211 217
22. H.C. Box, H.B. Patrzyc, J.B. Dawidzik, H. Iijima, H.G. Freund, A. Higbee, and E.E. Budzinski Detection and characterization of formamido lesions in DNA by liquid chromatography-mass spectrometry Radiat. Res. 158 2002 538 542
23. R.P. Perez Cellular and molecular determinants of cisplatin resisitance Eur. J. Cancer 34 1998 1535 1542
24. V.M. Gonzalez, M.A. Fuertes, C. Alonso, and J.M. Perez Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol. 59 2001 657 663
25. 2] Nucleic Acids Res. 24 1996 336 341
26. 4 J. Inorg. Biochem. 78 2000 313 321
27. C. Manzotti, G. Pratesi, E. Menta, D.R. Di, E. Caballetti, H.H. Fiebig, N. Farrell, D. Polizzi, R. Supino, G. Pezzoi, and F. Zunino BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin Clin. Cancer Res. 6 2000 2626 2634
28. F.J. Dijt, A.M. Fichtinger-Schepman, F. Berends, and J. Reedijk Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts Cancer Res. 48 1998 6058 6062
29. M. Sharma, J. Jain, E. Ionescu, and H.K. Slocum Capillary electrophoretic separation and laser-induced fluorescence detection of the major DNA adducts of cisplatin and carboplatin Anal. Biochem. 228 1995 307 311